Iranian Journal of Basic Medical Sciences
Medical Sciences
https://ijbms.mums.ac.ir/
0
2008-3866
2008-3874
en
jalali
0
0
1
gregorian
2015
5
1
18
5
online
1
fulltext
en
PI3K/Akt inhibition and down-regulation of BCRP re-sensitize MCF7 breast cancer cell line to mitoxantrone chemotherapy
Original Article
Breast Cancer, BCRP, Combination therapy, Mitoxantrone, PI3K/Akt, siRNA
472
477
https://ijbms.mums.ac.ir/article_4410.html
Tahereh
Komeili-Movahhed
17083
No
Molecular Research Laboratory, Department of Pharmacology and Toxicology, Tehran University of Medical Sciences, Tehran, Iran|Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran
Shamileh
Fouladdel
sfouladd@med.umich.edu
17084
No
Molecular Research Laboratory, Department of Pharmacology and Toxicology, Tehran University of Medical Sciences, Tehran, Iran
Elmira
Barzegar
barzegar_e@razi.tums.ac.ir
17085
No
Molecular Research Laboratory, Department of Pharmacology and Toxicology, Tehran University of Medical Sciences, Tehran, Iran
Shekoufeh
Atashpour
sh_atashpoor@yahoo.com
17086
No
Molecular Research Laboratory, Department of Pharmacology and Toxicology, Tehran University of Medical Sciences, Tehran, Iran
Mohammad Hossein
Ghahremani
17087
No
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran|Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
Seyed Nasser
Ostad
ostadnas@tums.ac.ir
17088
No
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
Zahra
Madjd
zahra.madjd@yahoo.com
17089
No
Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran
Ebrahim
Azizi
aziziebr@tums.ac.ir
17090
Yes
Molecular Research Laboratory, Department of Pharmacology and Toxicology, Tehran University of Medical Sciences, Tehran, Iran